68Ga-PSMA-11 PET/CT早期动态显像可区分膀胱尿液活动与前列腺癌病灶
回顾性分析80例连续接受68Ga-PSMA-11 PET/CT的前列腺癌患者,注射后前8分钟行盆腔早期动态显像,并与注射后60分钟全身显像比较。55个恶性病灶在早期动态显像中均于前3分钟内出现摄取,而所有患者膀胱在前3分钟内无活动;生化复发亚组局部复发检出率由20.3%提高至29.7%。
要点
- 所有恶性病灶在注射后前3分钟内即出现68Ga-PSMA-11摄取,所有患者膀胱在前3分钟内无活动。
- 前6分钟内前列腺癌病灶SUVmax显著高于膀胱蓄积(p < 0.001)。
- 生化复发亚组局部复发检出率由20.3%提高至29.7%。
核心结论
- 68Ga-PSMA-11 PET/CT早期动态显像能可靠区分前列腺癌病灶的病理性摄取与膀胱生理性蓄积。
- 在注射后60分钟全身显像基础上加做早期动态显像,可能提高生化复发患者局部复发的检出率。
研究设计与样本
- 回顾性分析纳入80例连续转诊行68Ga-PSMA-11 PET/CT的前列腺癌患者,其中生化复发64例、原发分期8例、疗效评估/再分期8例。
- 除注射后60分钟全身PET/CT采集外,于注射后前8分钟行盆腔早期动态显像,计算病灶SUVmax并生成时间-活性曲线,与膀胱及生理性摄取区域比较。
主要发现
- 60分钟全身显像上符合恶性的55个病灶在早期动态显像中也显示病理性68Ga-PSMA-11摄取(前列腺床/前列腺腺体27个、淋巴结12个、骨16个)。
- 所有病理性病灶均在动态显像前3分钟内出现示踪剂摄取,而所有患者膀胱在动态显像前3分钟内无活动。
- 前6分钟内前列腺癌病灶SUVmax显著高于膀胱蓄积(p < 0.001)。
- 生化复发亚组中局部复发检出率由20.3%提高至29.7%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: PET/CT with 68Ga-labelled prostate-specific membrane antigen (PSMA)-ligands has been proven to establish a promising imaging modality in the work-up of prostate cancer (PC) patients with biochemical relapse. Despite a high overall detection rate, the visualisation of local recurrence may be hampered by high physiologic tracer accumulation in the urinary bladder on whole body imaging, usually starting 60 min after injection. This study sought to verify whether early dynamic 68Ga-PSMA-11 (HBED-CC)PET/CT can differentiate pathologic PC-related tracer uptake from physiologic tracer accumulation in the urinary bladder. METHODS: Eighty consecutive PC patients referred to 68Ga -PSMA-11 PET/CT were included in this retrospective analysis (biochemical relapse: n = 64; primary staging: n = 8; evaluation of therapy response/restaging: n = 8). In addition to whole-body PET/CT acquisition 60 min post injection early dynamic imaging of the pelvis in the first 8 min after tracer injection was performed. SUVmax of pathologic lesions was calculated and time-activity curves were generated and compared to those of urinary bladder and areas of physiologic tracer uptake. RESULTS: A total of 55 lesions consistent with malignancy on 60 min whole body imaging exhibited also pathologic 68Ga-PSMA-11 uptake during early dynamic imaging (prostatic bed/prostate gland: n = 27; lymph nodes: n = 12; bone: n = 16). All pathologic lesions showed tracer uptake within the first 3 min, whereas urinary bladder activity was absent within the first 3 min of dynamic imaging in all patients. Suvmax was significantly higher in PC lesions in the first 6 min compared to urinary bladder accumulation (p < 0.001). In the subgroup of PC patients with biochemical relapse the detection rate of local recurrence could be increased from 20.3 to 29.7%. CONCLUSIONS: Early dynamic imaging in 68Ga-PSMA-11 PET/CT reliably enables the differentiation of pathologic tracer uptake in PC lesions from physiologic bladder accumulation. Performance of early dynamic imaging in addition to whole body imaging 60 min after tracer injection might improve the detection rate of local recurrence in PC patients with biochemical relapse referred for 68Ga-PSMA-11 PET/CT.
引用
- Uprimny C, Kroiss AS, Decristoforo C, et al. Early dynamic imaging in 68Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesions. Eur J Nucl Med Mol Imaging. 2016. PMID: 27900519. doi:10.1007/s00259-016-3578-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。